The development of Alzheimer’s Disease (AD), Parkinson’s Disease (PD) and Multiple Sclerosis (MS), through varying mechanisms, have been evidenced to prime and activate the NLRP3 inflammasome, which subsequently mediates further inflammation and damage. The gene discussed is NLRP3; the disease is myeloid sarcoma.